October 10, 2008 09:20 ET

SOHM, Inc. Focuses on Manufacturing Agreements and Acquisitions Within India's Pharmaceutical Sector

Exports From India Operations to Emerging Markets in Africa, Latin America, and Southeast Asia Expected to Be Strong

BUENA PARK, CA--(Marketwire - October 10, 2008) - SOHM, Inc. (PINKSHEETS: SHMN), a leading US-based Import Export Organization specializing in global trading through China and India, announced today that it is currently completing manufacturing agreements with a series of pharmaceutical companies in India. These agreements will accelerate growth by establishing a manufacturing hub for the production of generic pharmaceuticals. These pharmaceuticals will be exported globally with a focus on distribution in Africa, Latin America, and Southeast Asia. Alliances are also expected to culminate in accretive acquisitions increasing profit margins and the scalability of manufacturing operations.

Vice President for Corporate Strategy at SOHM, Inc. stated, "Growth is shifting away from developed markets in the U.S. and Europe and toward emerging markets as less developed countries prosper and spend more money on healthcare."

India has a significant share in the global generics market and is ranked third in the world. Three factors favoring the company's manufacturing hub in India are a strong marketing set up, low prices and the advantage of using the English language. With domestic drug sales of almost $5 billion, Indian companies have also developed a considerable service industry for the global pharmaceutical market.

Pharmaceutical Market Statistics

--  Growing at a CAGR of around 8%, the global pharmaceutical market is
    forecasted to reach US$ 1043.4 Billion in 2012.
--  A large untapped population and strong economic growth in major
    countries is expected to make Asia-Pacific the most lucrative
    pharmaceutical market in future.
--  Growth in the Latin American markets is expected to be strong with
    Brazil and Mexico amongst the most emerging pharmaceutical markets in the
--  North America remains the largest pharmaceutical market constituting
    42.8% of the global sales in 2007. Growth in the region is however expected
    to slow down in near future owing to patent expiration of key drugs and
    increased prevalence of generics.
--  In Europe, growth in the top five markets is expected to remain
    sluggish in next five years. Emerging markets in Central and Eastern Europe
    is however expected to drive growth in future.

About SOHM, Inc.

SOHM, Inc. is a leading US-based Import Export Organization specializing in global trading of a diversified product portfolio ranging from Manufacturing, Medical Equipment, Pharmaceuticals and Chemicals.

The Company has established and maintains long standing relationships in China and India which are the world's largest product suppliers. Our Asia-Pacific manufacturers allow us to import, export, and/or source quality products in China and India; sharply reducing business costs and increasing the profits of our client corporations.

Safe Harbor Statement

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact Information

  • For more information, please contact:
    SOHM, Inc.
    Investor Relations
    (714) 522-6700
    Email Contact